Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    No substantial additions or deletions were detected; the study details page content remains unchanged aside from minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:08:23.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:59:37.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T07:34:59.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a minor patch; no substantive changes to core content or critical data. A Back to Top link was removed as a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T23:33:52.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T20:07:24.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for cyclophosphamide anhydrous, fludarabine, lifileucel, and pembrolizumab, while removing some previously listed drug information and location details.
    Difference
    3%
    Check dated 2025-08-31T12:35:43.000Z thumbnail image

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.